Presented by The Children's National Medical Center

• Over 88% of respondents to a survey of previous participants indicated they had passed the certification examination
• Strong emphasis on approaches to board-exam type questions
• A comprehensive and up-to-date review of the theory and practice of pediatrics

The Pediatric Board Review is designed and recommended for physicians preparing for either the certification or the recertification examination of the American Board of Pediatrics in General Practice. The practicing pediatrician, family physician, or pediatric sub-specialist who is not considering either examination will also benefit from this intensive refresher course in pediatrics. For those individuals who have had difficulty preparing for and taking examinations, this program offers not only an extensive review of content, but also practice in visual diagnosis and experience in taking a practice examination under simulated conditions.

An extensive 600-plus page bound syllabus with text and supplemental slide of each resentation serves as the course textbook and as an invaluable resource.

CME credit is obtained upon successful completion of a post-test, self - assessment examination and activity evaluation. A $30 processing fee must accompany the completed exam and evaluation application.

Learning Objectives

At the conclusion of this course, participants should be able to:

• demonstrate increased knowledge of general pediatrics
• compare current knowledge with information presented
• identify areas of weakness requiring further study
• integrate the extensive syllabus with current resources
• recognize the format and style of Board questions
• experience a greater degree of confidence in preparing for the Board examination

Faculty Disclosure

It is the policy of The George Washington University Medical Center, Office of Continuing Education in the Health Professions to insure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. All faculty participating in any activities which are designated for AMA-PRA credits are expected to disclose to the audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the CME activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented.